Rheumatoid Arthritis
Rheumatoid Arthritis (RA) is an autoimmune disorder that primarily affects the joints, causing inflammation, pain, and stiffness, particularly in the morning or after periods of inactivity.
Rheumatoid Arthritis: GS-0151 Treatment Study
We are investigating a new medication, GS-0151, for people with rheumatoid arthritis. The goal is to see how it may help manage symptoms and improve quality of life.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Universitaetsklinikum Bonn AöR
Med. Klinik III
Bonn, Germany
Krankenhaus Porz Am Rhein gGmbH
Klinik für Rheumatologie
Eil, Germany
MVZ Rheumatologie und Autoimmunmedizin Hamburg GmbH
Hamburger Rheuma Forschungszentrum II
Hamburg, Germany
Sponsor: Gilead Sciences Inc.
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.